Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
May 14, 2012
Company News
Takeda gastrointestinal news
...the pharma under-allocated its U.S. earnings in relation to transactions of Prevacid between Takeda and
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
Apr 16, 2012
Company News
Takeda gastrointestinal news
...U.S. earnings in relation to product supply and license transactions of Prevacid between Takeda and
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
Apr 4, 2011
Company News
CSL, Abbott, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Merck, Pfizer, sanofi-aventis, Takeda pharmaceuticals news
...and sanofi-aventis. CSL's ZLB Behring LLC subsidiary was also named in the suit, as was
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
Oct 4, 2010
Company News
CSL, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Pfizer, sanofi-aventis pharmaceuticals news
...Pfizer, argue that the entities do not have standing to sue under the 340B statute.
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 11, 2009
Company News
Shire, Takeda, Teva deal
...Shire said the termination was for strategic reasons. The original deal was between Shire and
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 26, 2008
Clinical News
TAK-390MR: Phase III data
...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 26, 2008
Clinical News
TAK-390MR: Phase III data
...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 26, 2008
Clinical News
TAK-390MR: Phase III data
...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 5, 2008
Company News
Abbott, Takeda deal
...Abbott and Takeda completed the previously announced closing of their
Tap Pharmaceutical Products Inc.
JV (see BioCentury, March 24...
Read More
BioCentury
|
Mar 31, 2008
Company News
Shire, Tap Pharmaceutical sales and marketing update
...and the Pacific Rim from Giuliani S.p.A. (Milan, Italy). Shire plc (LSE:SHP; NASDAQ:SHPGY), Basingstoke, U.K.
Tap Pharmaceutical Products Inc.
...
Read More
Items per page:
10
1 - 10 of 82
BioCentury
|
May 14, 2012
Company News
Takeda gastrointestinal news
...the pharma under-allocated its U.S. earnings in relation to transactions of Prevacid between Takeda and
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
Apr 16, 2012
Company News
Takeda gastrointestinal news
...U.S. earnings in relation to product supply and license transactions of Prevacid between Takeda and
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
Apr 4, 2011
Company News
CSL, Abbott, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Merck, Pfizer, sanofi-aventis, Takeda pharmaceuticals news
...and sanofi-aventis. CSL's ZLB Behring LLC subsidiary was also named in the suit, as was
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
Oct 4, 2010
Company News
CSL, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Pfizer, sanofi-aventis pharmaceuticals news
...Pfizer, argue that the entities do not have standing to sue under the 340B statute.
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 11, 2009
Company News
Shire, Takeda, Teva deal
...Shire said the termination was for strategic reasons. The original deal was between Shire and
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 26, 2008
Clinical News
TAK-390MR: Phase III data
...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 26, 2008
Clinical News
TAK-390MR: Phase III data
...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 26, 2008
Clinical News
TAK-390MR: Phase III data
...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan
Tap Pharmaceutical Products Inc.
...
Read More
BioCentury
|
May 5, 2008
Company News
Abbott, Takeda deal
...Abbott and Takeda completed the previously announced closing of their
Tap Pharmaceutical Products Inc.
JV (see BioCentury, March 24...
Read More
BioCentury
|
Mar 31, 2008
Company News
Shire, Tap Pharmaceutical sales and marketing update
...and the Pacific Rim from Giuliani S.p.A. (Milan, Italy). Shire plc (LSE:SHP; NASDAQ:SHPGY), Basingstoke, U.K.
Tap Pharmaceutical Products Inc.
...
Read More
Items per page:
10
1 - 10 of 82
Previous page
Next page